It is beyond the scope of this study to characterize the role of CASZ1 in a normal neural crest development model, but our results provide interesting insights into how loss of a tumor suppressor gene such as CASZ1 might contribute to the oncogenic dysregulation of lineage specifying CRC such as occurs in NB. The gene discussed is CASZ1; the disease is neuroblastoma.